Rosen Law Firm, a global investor rights law firm, reminds purchasers of Adeptus Health securities (NYSE:ADPT): (1) from April 23, 2015 through November 16, 2015, both dates inclusive; and/or (2) pursuant and/or traceable to Adeptus Health's secondary public offering on or about July 31, 2015 of the important December 27, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Adeptus Health investors under the federal securities laws. To join the Adeptus Health class action, go to the firm's website at http://rosenlegal.com/cases-789.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for more information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Adeptus Health was engaging in predatory billing practices, which exposed Adeptus Health to numerous risks and possible penalties, including civil and/or criminal sanctions, and exclusion from federal and/or state healthcare programs; (2) Adeptus Health's financial statements had not been prepared in conformity with generally accepted accounting principles; and (3) contrary to representations about Adeptus Health's practice of referring lower acuity patients to urgent care facilities, it routinely treated and excessively billed these patients. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 27, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm's website at http://rosenlegal.com/cases-789.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org. Attorney Advertising. Prior results do not guarantee a similar outcome. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.